Citigroup
CMPX icon

Citigroup’s Compass Therapeutics CMPX Stock Holding History

Citigroup’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Buy
713,907
+115,669
+19% +$341K ﹤0.01% 3115
2026
Q1 		$3.16M Buy
598,238
+336,362
+128% +$1.94M ﹤0.01% 2325
2025
Q4 		$1.41M Buy
261,876
+251,225
+2,359% +$1.16M ﹤0.01% 2903
2025
Q3 		$37.3K Sell
10,651
-21,059
-66% -$66.5K ﹤0.01% 4583
2025
Q2 		$82.4K Sell
31,710
-99,527
-76% -$205K ﹤0.01% 4504
2025
Q1 		$249K Buy
131,237
+52,634
+67% +$140K ﹤0.01% 4068
2024
Q4 		$114K Buy
78,603
+4,322
+6% +$7.18K ﹤0.01% 4766
2024
Q3 		$137K Buy
74,281
+51,150
+221% +$63.8K ﹤0.01% 4611
2024
Q2 		$23.1K Buy
23,131
+6,089
+36% +$8.89K ﹤0.01% 4962
2024
Q1 		$33.7K Buy
17,042
+3,640
+27% +$6.29K ﹤0.01% 4830
2023
Q4 		$20.9K Buy
13,402
+13,219
+7,223% +$22.9K ﹤0.01% 4973
2023
Q3 		$361 Sell
183
-28,905
-99% -$71.5K ﹤0.01% 5250
2023
Q2 		$92.5K Sell
29,088
-113,853
-80% -$357K ﹤0.01% 4287
2023
Q1 		$467K Buy
142,941
+16,626
+13% +$65.3K ﹤0.01% 3171
2022
Q4 		$635K Buy
126,315
+121,782
+2,687% +$486K ﹤0.01% 2993
2022
Q3 		$10K Buy
4,533
+3,163
+231% +$8.76K ﹤0.01% 4980
2022
Q2 		$4K Buy
+1,370
New +$2.97K ﹤0.01% 5666
2022
Q1 		– Sell
-37,834
Closed -$120K – 6338
2021
Q4 		$120K Buy
+37,834
New +$125K ﹤0.01% 4638

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citigroup's CMPX Position: Q2 2026 in Review

Citigroup increased its Compass Therapeutics (CMPX) stake by 19% in Q2 2026, buying an estimated $341K and bringing the position to 713,907 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #3115.

Citigroup first reported a position in CMPX in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.16M in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Citigroup held 713,907 shares of Compass Therapeutics worth $1.56M as of Q2 2026.
  • Citigroup bought 115,669 Compass Therapeutics shares in Q2 2026, an estimated $341K.
  • Compass Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3115 holding.
  • Citigroup first reported a position in Compass Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • Citigroup's Compass Therapeutics position peaked at $3.16M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.